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Viral vectors are promising tools for the dissection of neural circuits. In principle, they can
manipulate neurons at a level of specificity not otherwise achievable. While many studies
have used viral vector-based approaches in the rodent brain, only a few have employed
this technique in the non-human primate, despite the importance of this animal model
for neuroscience research. Here, we report evidence that a viral vector-based approach
can be used to manipulate a monkey’s behavior in a task. For this purpose, we used
the allatostatin receptor/allatostatin (AlstR/AL) system, which has previously been shown
to allow inactivation of neurons in vivo. The AlstR was expressed in neurons in monkey
V1 by injection of an adeno-associated virus 1 (AAV1) vector. Two monkeys were trained
in a detection task, in which they had to make a saccade to a faint peripheral target.
Injection of AL caused a retinotopic deficit in the detection task in onemonkey. Specifically,
the monkey showed marked impairment for detection targets placed at the visual field
location represented at the virus injection site, but not for targets shown elsewhere.
We confirmed that these deficits indeed were due to the interaction of AlstR and AL
by injecting saline, or AL at a V1 location without AlstR expression. Post-mortem histology
confirmed AlstR expression in this monkey. We failed to replicate the behavioral results
in a second monkey, as AL injection did not impair the second monkey’s performance
in the detection task. However, post-mortem histology revealed a very low level of AlstR
expression in this monkey. Our results demonstrate that viral vector-based approaches can
produce effects strong enough to influence a monkey’s performance in a behavioral task,
supporting the further development of this approach for studying how neuronal circuits
control complex behaviors in non-human primates.
Keywords: monkey, V1, viral vector, inactivation, visual detection
INTRODUCTION
Over the last several years, neuroscience has seen the development
of a set of exciting new tools for probing brain function with a
high degree of specificity (Luo et al., 2008). These tools are based
on introducing novel channels or receptors into neurons through
the use of viral vectors. The channels or receptors are designed
such that they can be used to control the activity of the infected
neurons. By limiting which neurons express the novel channels or
receptors, manipulations can be restricted to selected populations
of neurons.
Viral vector-based approaches are now widely used in a num-
ber of animal models, with most experiments focusing on the
rodent (see Fenno et al., 2011 for an overview of studies using
optogenetic approaches). Only a few experiments have used these
tools in the non-human primate, despite the importance of this
animal model for neuroscience. Non-human primates, such as
the Rhesus macaque, are highly intelligent and can be trained
to perform the complex tasks needed to study higher cogni-
tive functions. A wealth of research has identified the functional
specializations across different areas of the macaque brain, and
the connections within and between these brain areas have been
identified anatomically (Felleman andVan Essen, 1991), but func-
tional roles have yet to be assigned to these circuits because of
a lack of suitable tools. The specificity of the viral vector-based
approach promises to overcome this obstacle. However, to be use-
ful in the monkey, viral vector-based methods have to meet a few
requirements besides cell-type specificity. First, injections of virus
into the monkey brain have to result in expression of the novel
channels or receptors in neurons. Furthermore, expression lev-
els have to be sufficient to allow manipulation of neural activity.
Finally, in order to study the involvement of a particular group
of neurons in a behavioral task, manipulations of neural activ-
ity have to be strong enough to result in measurable changes in
behavior.
There are a large number of anatomical studies showing that
viral vectors can be used to introduce fluorescent proteins into
neurons (Luo et al., 2008). There are also a few studies demon-
strating that viral vectors can be used to outfit neurons in the
macaque brain with novel channels or receptors, which in turn
allow control over neural activity (Tan et al., 2006; Han et al.,
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2009, 2011; Diester et al., 2011; Jazayeri et al., 2011; O’Shea et al.,
2011). There is, however, conflicting evidence on whether these
manipulations are sufficiently strong to manipulate behavior in
the awake monkey. Four of the mentioned studies, all using opto-
genetic approaches, have tested whether activation or inactivation
of neurons using light had behavioral consequences. Two of the
studies (Han et al., 2009; Diester et al., 2011), in which viral
injections were placed in motor areas, assessed whether optoge-
netic manipulations of neural activity in these areas were strong
enough to influence spontaneous movements. In both cases, no
effect of optogenetic stimulation on spontaneous behavior was
observed. The two more recent studies (Jazayeri et al., 2011;
O’Shea et al., 2011) studied behavioral consequences of optoge-
netic stimulation during a task. Both studies—one assessing the
influences of V1 stimulation on a saccade task, and one the influ-
ences of premotor cortex inactivation on a reaching task—found
small, but systematic changes in behavior during optogenetic
stimulation. The small size of the evoked effects is most likely
the reason why the initial studies failed to find an effect on spon-
taneous movements, and points to the difficulty of using a viral
vector-based approach in the monkey.
In this study, we report additional evidence that a viral vector-
based approach can been used to manipulate a monkey’s behavior
in a task. In these experiments, we used the allatostatin recep-
tor/allatostatin (AlstR/AL) system (Birguel et al., 1999; Lechner
et al., 2002) to reversibly inactivate neurons in macaque area V1.
It has previously been shown that application of AL quickly and
reversibly inactivates AlstR-expressing neurons in vivo (Tan et al.,
2006) through opening of G-coupled inward rectifying K+ chan-
nels (Birguel et al., 1999; Lechner et al., 2002). In vivo, neurons
expressing the AlstR are inactivated within a few minutes after AL
application, and remain inactivated as long as they are exposed
to sufficient amounts of AL. Fast recovery of neural activation is
possible if the AL can be efficiently removed, for example by flush-
ing the cortex with saline. In these cases, activity recovers within
a few minutes. AL also is cleared from the brain by physiological
processes, in which case the recovery of activity is slower and may
take up to a few hours (Tan et al., 2006). The AlstR/AL system
therefore does not allow the same precise temporal control over
neural activity afforded by optogenetic stimulation. However, it
may allow us to target larger populations of neurons than an
optogenetic approach. The brain volume that can be targeted by
optogenetic manipulations is limited by the fact that because of
absorption, light levels in the brain drop with distance from the
light source and eventually become too small to trigger changes
in neural activity. For Channelrhodopsin-2 (ChR2), a light-gated
cation channel (Boyden et al., 2005) activated by blue light, acti-
vation volumes of up to 1mm3 have been estimated (Aravanis
et al., 2007; Han et al., 2009). In case of the AlstR/AL system, the
size of the targeted brain volume is determined by the diffusion
of the ligand AL, which mainly depends on the amount of AL
injected. The size of the brain volume that can be targeted using
the AlstR/AL system is therefore likely larger than that accessible
with optogenetic stimulation.
Here, we demonstrate that inactivation of AlstR-expressing V1
neurons was sufficient to impair one monkey’s performance in
a detection task. While these results show encouraging progress
for using viral vector-based approaches in the monkey, we also
demonstrate the complications of the technique by showing how
large variability in AlstR expression between monkeys led to
failure to produce behavioral results in a second monkey.
MATERIALS AND METHODS
We used the same laboratory setup as described previously (Hafed
et al., 2008; Lovejoy and Krauzlis, 2010).
ANIMAL PREPARATION
We collected data from two adult, male rhesus monkeys (Macaca
mulatta). Monkeys were 9–15 years of age and weighed 10–15 kg.
All experimental protocols were approved by the Salk IACUC
and complied with United States Public Health Service policy on
the humane care and use of laboratory animals. The monkeys
were prepared using standard surgical techniques described pre-
viously (Krauzlis, 2003). Briefly, a head-holder, scleral search coils
(Judge et al., 1980), and a recording chamber located over V1were
implanted under isoflurane anesthesia and aseptic conditions.
BEHAVIORAL TASKS
Stimuli were presented on a CRT monitor (75Hz refresh rate)
placed 41 cm in front of the monkeys. Monkeys were trained on
two tasks: a passive viewing task and a detection task. In the pas-
sive viewing task, monkeys were required to maintain fixation of a
central white square (size: 0.27 × 0.27◦) presented over a uniform
gray background (luminance: 45 cdm−2). Each trial began with
the presentation of the fixation point alone for a variable time
between 300 and 800ms, followed by the addition of a full con-
trast grating of 0.5–1◦ radius on the screen for 300–800ms. The
grating’s location and orientation were varied from trial-to-trial
to map the receptive field of the recorded neuron. The monkeys
were required to maintain fixation 300ms after the offset of the
grating. In this passive viewing task, fixation had to be main-
tained within a 1 × 1◦ window centered on the fixation target for
monkey W, and a 2 × 2◦ window for monkey V.
The detection task consisted of two types of trials, distin-
guished by whether or not a peripheral target was presented (see
Figure 1). Eighty percent of the trials in a session were target-
present trials. All trials began with the presentation of a central
white fixation square (size: 0.16 × 0.16◦) on a trial-unique, noise-
textured background (size: 10 × 10◦). The rest of the screen,
outside of the texture, was set to a uniform gray (luminance:
45 cdm−2). The noise texture was constructed by assigning each
of its pixels a gray scale value independently drawn from a
Gaussian distribution. The mean of the Gaussian distribution was
chosen to match the luminance of the rest of the screen, and the
standard deviation σtexture was fixed at 5.5 cd/m−2. Pixel values
outside of the range from 0 to 255 were set to either 0 or 255,
respectively. In the target-absent trials, the central fixation square
was presented for a variable time between 800 and 1400ms before
its color changed to red. After another 300–1000ms, the fixation
square and texture were removed, and the entire screen turned
gray. In these target-absent trials, monkeys were rewarded if they
maintained fixation of the central square as long as it was visi-
ble, irrespective of its color. In the target-present trials, the initial
presentation of fixation square and texture was followed after
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FIGURE 1 | (A) Stimulus sequences in the two trial types (see text for a
description of the task). (B) Receptive fields and target locations for the two
monkeys. Black ellipses: Receptive field locations recorded at the V1 site
selected for virus injection, computed from single unit and multiunit activity
(see Materials and Methods). The red and green circles indicate the two
target locations. Red circle: AlstR location; green circle: contralateral location.
500–800ms by the additional appearance of a small peripheral
target. Targets measured 0.16 × 0.16◦ (3 × 3 pixels at our screen
resolution and viewing distance), and were generated by adding a
luminance increment to the gray scale values of the texture pixels
at the target location. Luminance increments were expressed in
terms of σtexture. Four different luminance increments were cho-
sen for monkey W (1, 1.5, 2, 3, and 4 × σtexture). For monkey V,
we added a fifth luminance increment (5 × σtexture) to decrease
the overall task difficulty. Four target locations were used, cho-
sen based on which injection site was visited. After an additional
300–600ms, the fixation square turned red. The monkeys were
required to maintain fixation within a window centered on the
fixation square until this time. After the fixation spot changed
color, they were trained to make a saccade directly to the location
of the target: within 600ms after the color change, their center of
gaze had to leave the fixation window; after another 100ms, it had
to fall within a second window centered on the target’s location.
After an additional fixation period of 300ms, the entire screen
turned gray to indicate the end of the trial.
Throughout the detection task, the fixation window had a size
of 2 × 2◦ for monkey W, and of 3 × 2◦ for monkey V. Correct
behavior was rewarded with juice, but to mask increased error
rates in inactivation experiments, only 90% of the correct trials
were rewarded.
ELECTROPHYSIOLOGICAL RECORDINGS
Neuronal responses were recorded using tungsten microelec-
trodes (FHC) with impedances of 1–2M measured at 1 kHz.
Electrodes were advanced through stainless steel guide tubes
(23 gauge) with a microdrive mounted on top of the recording
chamber (Narishige), which also held the guide tube. Neuronal
responses were amplified and filtered (400Hz–6 kHz) using the
Multichannel Acquisition Processor system (Plexon, Inc.). Data
were streamed to disk at 20 kHz using a Power1401 data acqui-
sition interface and the Spike2 software (both from Cambridge
Electronic Design). In a few initial experiments with monkey W,
instead of streaming the data to disk directly, we isolated spikes
from single neurons using Plexon’s box-sort algorithm. Spike
times were then recorded at 1 kHz resolution.
VIRUS
The virus construct used in these experiments was an adeno-
associated virus 1 (AAV1) containing an AlstR-IRES2-EGFP
expression cassette under the control of a human synapsin pro-
moter (Tan et al., 2006). Virus was produced and titered as
described previously (Tan et al., 2006). Two batches of virus
were used, with initial viral titers of 3.7 × 1011 particles/mL (first
injection in monkey W) and 5.3 × 1012 particles/mL (all other
injections).
VIRUS INJECTION
We injected virus using a custom-made apparatus modified from
Chen et al. (2001). Briefly, the injection device consisted of ametal
cannula (30 gauge) with an electrode threaded through its center.
The cannula was connected to a 10μL Hamilton syringe using
thin plastic tubing. In both monkeys we injected virus at four
locations, arranged to form a 1mm wide square. At each loca-
tion, virus was injected at three depths (0.2, 0.6, and 1mm above
the transition from gray to white matter), and at each depth, we
injected between 0.5 and 0.8μL of virus. Each individual injec-
tion took between 20 and 80min, and we waited for 5min after
each injection before moving the injection device to a new depth.
In monkey W, injections were completed within three days, in
monkey V within two days.
Placement of injections was verified using landmarks deter-
mined in prior recording sessions from the same V1 locations.
These landmarks were the receptive field locations and the depth
of the transition from gray to white matter at each recording site.
AL AND SALINE INJECTION
AL and saline were injected using the same type of custom-made
apparatus used for injecting viruses. The Drosophila AL peptide
Ser-Arg-Pro-Tyr-Ser-Phe-Gly-Leu-NH2 (Birguel et al., 1999) was
synthesized in house and stored in 100 uM aliquots in water at
−80◦C. For experiments, AL was diluted to 1μM in saline. In
one injection in monkey V, we used 2μM AL.
Both AL and saline were continuously infused for the duration
of the experiment. We began behavioral testing after injection of
1μL. Infusion rate was set at 0.05μL/min for the first microliter,
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and then slowed down so that the speed across the entire exper-
iment was on average 0.03μL/min (range: 0.02–0.04μL/min).
On average, we injected a total of 2.6μL of fluid per experiment
(range: 2.0–3.5μL). AL and saline infusions were carried out at
least one month after virus injection (monkey W: 1–6 months,
monkey V: 1.5–2 months).
HISTOLOGY
At the end of the experiments (2.5 and 1.5 years after the first
virus injection for monkey W and V, respectively), monkeys
were sacrificed, perfused with fixative, and their brains were
removed. 50μm thick sections were cut on a freezing microtome
parasagitally. Every fourth section was stained for expression
of GFP. Immunohistochemistry for GFP was performed using
a rabbit anti-GFP antibody (Invitrogen, 1:500), a biotinylated
goat anti-rabbit secondary antibody (Jackson ImmunoResearch,
1:2000), and an ABC avidin-peroxidase kit (Vector Laboratories),
followed by the Vector VIP peroxidase substrate kit (Vector
Laboratories).
DATA ANALYSIS
Neurophysiology
Multiunit activity (MUA) was computed from the continuously
acquired neuronal responses by rectifying, filtering (low-pass fil-
ter, cut-off 150Hz) and downsampling the recorded signals to
1 kHz. Receptive field locations were then computed from MUA
or spike times by first computing the stimulus evoked response
for every trial as the average response in the 300ms time win-
dow following stimulus onset, corrected by the baseline response
computed across the 100ms interval preceding stimulus onset.
Repeated presentations of the same stimulus location were then
averaged, and the location of the receptive field was determined by
fitting the resulting data set with a 2D Gaussian profile. Receptive
fields were then described by plotting the ellipse falling at the full
width at half maximum (FWHM) of the Gaussian fit.
Behavioral data
For each experiment, we computed the percentage of correct
responses as a function of target location and target luminance
increment. These data were fit with the psychometric function:
(x;α, β, λ) = (1 − λ) F (x;α, β),
where λ is the lapse rate, and F(x; α, β) is a Weibull function with
parameters α and β. This function was fitted via maximum like-
lihood estimation using Palamedes (Prins and Kingdom, 2009).
Palamedes was also used to determine the goodness-of-fit for
each fit by computing the deviance (Wichmann and Hill, 2001).
Each deviance value was then compared against a distribution of
deviance values computed using a bootstrap method and 1000
iterations, and only fits with deviance values falling above the
fifth percentile of the simulated distribution were included in the
analysis.
Histology
Cell counts were obtained from sections spaced 400μm apart. In
each section containing labeled neurons, we plotted the positions
of neuronal cell bodies labeled with GFP using Neurolucida
software (MicroBrightField). Cells were visualized and plotted
with a 40× objective. Only cells for which the entire circum-
ference of the soma was visible were counted. Glial cells were
identified based on their characteristic morphology and excluded
from the cell count. For each of the sections, we also marked the
boundary between gray and white matter, and gray matter and
pia. From the Neurolucida data, we first determined the num-
ber of infected cells per section. The Abercrombie correction
(Guillery, 2002) was applied to this cell count by multiplying it
with T/(T + h), where T is the thickness of the tissue (50μm),
and h is the height of the elements to be counted. h was measured
as the average diameter along the long axis of the counted cell
somata. To determine h, we chose the section with the largest cell
count for each of the three injection sites (one from monkey W,
two frommonkey V). In each section, we then measured the soma
diameter of 50 randomly chosen neurons, making sure that neu-
rons were selected across all layers. Since the average diameter was
similar across all three sections (10.37μm, 11.2μm, 9.96μm), we
used the average of all three values (10.51μm) for subsequent cell
count corrections. To determine the density of labeled neurons
per section, we also determined the area of tissue that contained
labeled neurons by computing the area within the complex hull
of the positions of labeled cells. Volume was then computed by
multiplying this area with the thickness of the section. One sec-
tion of monkey W had to be replaced with a neighboring section
(200μm apart) because of tissue damage. To compute the frac-
tion of neurons infected, we used the average density of neurons
across all layers of monkey V1 as reported by Beaulieu et al.,
114800 neurons/mm3 (Beaulieu et al., 1992).
In addition to computing cell densities for the entire section,
we also computed cell densities within smaller regions for each
section. For this purpose, we used the sameNeurolucida data con-
taining the position of all labeled cells within each section. For
each section, we counted the number of cells within a sliding,
round window of 100μm radius. The sliding window sampled
the section at steps of 10μm in both directions. Cell counts were
again corrected as described above, and the cell density was com-
puted for each window position by dividing the cell count by the
cylindrical volume covered by the window. This resulted in a den-
sity profile for each section, from which we could determine the
section’s maximum cell density.
RESULTS
The goal of the experiments was to test whether viral vector-
based approaches can be used to manipulate the performance of
monkeys in the types of complex tasks that have been used to
study higher-order brain functions. For this purpose, we tested
whether inactivation of V1 neurons using the AlstR/AL sys-
tem can cause measurable changes in a visual detection task.
Two monkeys (W and V) participated in the experiments. To
achieve AlstR expression, we used an AAV to deliver the required
genetic construct. AlstR expression was placed under the con-
trol of the human synapsin promoter (Tan et al., 2006). An
IRES2 element drove additional expression of GFP as a marker
for AlstR-expressing cells. In each monkey, we injected virus at a
site in V1 for which we had previously established receptive field
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locations by recording MUA (Figure 1B). Injections were made
at four locations targeted at the corners of a 1mm wide square,
injecting around 1.5μL of virus per location. At each location we
made injections at multiple depths, spaced such that injections
would be expected to span the entire extent of gray matter.
Approximately one month after virus injection, we began
to test whether inactivation of AlstR-expressing neurons by AL
application had behavioral consequences. Monkeys were trained
to perform a target detection task (Figure 1A). Each trial began
with the presentation of a fixation point, centered on a textured
background, which the monkeys were required to fixate. In most
of the trials, this was followed by the presentation of a periph-
eral target. A color change of the fixation point instructed the
monkeys to make a saccade to the target as quickly as possible.
Monkeys were required to land within a small window centered
on the target location after the very first saccade; monkeys were
not allowed to scan the display to search for the target. Targets
were defined by a luminance increment added to the textured
background at the target location. By changing the size of the
luminance increment (the “target strength”), we varied the task
difficulty. We assumed that in some trials the monkeys would not
be able to detect a target, especially after inactivation of V1. To
thwart the strategy of guessing in these trials, we introduced a
second set of trials in which no target was presented. In these
trials, the monkeys were required to maintain fixation until trial
end, even after the fixation spot changed color. Trials with and
without target presentation were randomly interleaved in every
experiment.
In the target-present trials, the target could appear at four dif-
ferent locations, chosen based on the receptive field locations at
the virus injection site. Only two of these locations were used
for further analysis. One location (the “AlstR location”) was cho-
sen such that the target fell within the receptive fields of neurons
recorded at the virus injection site. If the virus injections were suc-
cessful, targets presented at this location should be represented by
V1 neurons expressing the AlstR. As a within-experiment control,
a second target location was chosen in the contralateral hemifield
(the “contralateral location”), at the same eccentricity as the AlstR
location (see Figure 2A for a schematic overview of the differ-
ent experimental conditions). For every session and every target
location, we quantified the monkey’s behavior by computing the
percentage of correct target detections as a function of target
strength. These data were fit with a psychometric function con-
sisting of aWeibull function with parameters α and β. α represents
the threshold of the psychometric function, while β describes the
function’s slope. Since the monkey’s performance did not reach
100% correct even for the highest target strength in some experi-
ments (see below), we also included a lapse rate term λ in the fit,
which captures the deviation from perfect performance at high
target strengths.
In the first set of experiments, we injected AL at the virus
injection site in monkeyW. We continuously injected AL to guar-
antee maximal inactivation effects by targeting a large cortical
volume, and to provide stable inactivation conditions throughout
the experiment. AL injections markedly impaired the monkey’s
ability to detect targets shown at the AlstR location. Figure 2B
plots psychometric functions for the two target locations, both in
control experiments without injection (black line, contralateral
location: N = 26, AlstR location: N = 24), as well as in exper-
iments with continuous injection of AL (red lines, N = 4 for
both locations). Effects of AL injection on performance were
quantified by comparing the parameters of the fitted psychome-
tric functions between control and injection experiments using
a Mann–Whitney U-test. These comparisons demonstrate that
AL injection did not impair the monkey’s detection performance
for targets shown at the contralateral location: for targets shown
at this location, none of the fit parameters showed a significant
difference between control and AL data (α: U = 81, p = 0.2,
β: U = 38, p = 0.2, λ: U = 72, p = 0.6). At the same time, AL
injection did markedly impair the monkey’s performance when
targets were shown at the virus location—the visual field loca-
tion represented by the neurons at the virus injection site. While
there was no change in the slope β of the psychometric functions
during AL injection (U = 33, p = 0.1), AL injection significantly
increased the threshold α (U = 98, p = 0.01). This indicates that
the monkey had greater difficulty detecting targets at this loca-
tion during the AL injection. In addition, we also observed a
significant increase in the lapse rate λ (U = 106, p = 0.002):
as evident in Figure 2A, AL injection caused the monkey to
miss an increased number of targets, even for the highest signal
strength.
In addition to the target-present trials, the task also contained
trials in which no target was presented. In these trials, the monkey
was required tomaintain fixation on the centrally presented target
until its offset. We tested whether the AL injections impacted the
monkey’s performance in these target-absent trials. Performance
levels for the target-absent trials was high under control con-
ditions (average: 86% correct), and remained high during AL
injections (average: 87% correct). A comparison of performance
levels for the target-absent trials across experiments confirmed
that it was not influenced by AL injection (Mann–Whitney U-test:
U = 69, p = 0.8).
In summary, our data confirm that AL injection was sufficient
to disrupt the monkey’s performance in the detection task, but
only for targets shown at the AlstR location. The selectivity of the
effect suggests that the performance deficits during AL injection
were not simply due to a general change in performance in these
experiments, but instead were caused by the inactivation of the
AlstR-expressing V1 neurons that were responsible for encoding
the target when shown at the AlstR location.
In one set of control experiments, we confirmed that the
observed deficits where not simply due to disruption of neural
activity because of the injection of fluid into V1. We injected
saline at the virus injection site, with injection parameters
matched to the AL injections. The monkey’s detection perfor-
mance during saline injection is shown in Figure 2B (blue lines,
N = 2 for both locations). For both target locations, perfor-
mance during saline injection was not different from the control
experiments (p ≥ 0.2 for all parameters and target locations). We
also compared the performance during saline and AL injection
directly. This comparison is limited by the small sample sizes
(4 AL experiments vs. 2 saline experiments). For every fit parame-
ter and both target locations, we asked whether the fit parameter’s
value observed in the two saline experiments fell within the range
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FIGURE 2 | (A) Overview over the different experimental conditions.
Left: Stimulus configuration in control experiments. The top and bottom
panels indicate the two different target locations for which the monkey’s
performance is shown in (B). The region hatched in black indicates the part of
the visual field represented by neurons expressing the AlstR (not drawn to
size). Middle: The same stimulus configuration was used when injecting AL
or saline at the V1 site expressing the AlstR. In these panels, the region
hatched in red represents the part of the visual field targeted by the fluid
injection (not drawn to size). Right: In one experiment, AL was injected at a
V1 site not expressing the AlstR. (B) Performance of monkey W in the
detection task. The graph on the left plots behavior for targets shown at the
contralateral location; the graph on the right the behavior for targets shown at
the AlstR location. Black circles: Average performance in control experiments
without injection (error bars: SEM). Black line: Average psychometric function
fit to the control data. Red lines and triangles: Performance in individual AL
injection experiments (triangles: raw data; lines: psychometric function fit to
the different injection experiments). Blue squares and lines: Performance
(raw data and fit) during saline injection. (C) Performance during
AL injection at a V1 site not expressing the AlstR. The target was placed to
fall into the receptive field locations at this site (marked as “control site
location” in A). Black circles and line: Average behavior and
psychometric function in control experiments without injection (error bar:
SEM). Red triangles and line: Performance (raw data and fit) during AL
injection.
of values for the parameter observed during AL injection. For
targets shown at the contralateral location, this was the case for
all three parameters. Similarly, for targets shown at the virus loca-
tion, the value for β determined for the saline experiments fell
within the range observed during AL injection. However, both
saline experiments had smaller thresholds α than all of the AL
experiments. Also, the lapse rates λ in both saline experiments
were smaller than in all of the AL experiments. This is consistent
with the changes observed when comparing saline and AL exper-
iments against the control experiments without injections, which
found significant increases in α and λ in the AL experiments only.
Again, performance for the target-absent trials was not different
between saline and control experiments (U = 33, p = 0.8).
In a second set of control experiments, we tested whether the
observed deficits could be caused by the injection of AL with-
out involvement of the AlstR. We injected AL at a V1 site 4mm
distant to the virus injection site (“control site”). Receptive field
locations for the control site were established before AL injec-
tion. Figure 2C shows the monkey’s detection performance for
targets presented at a location falling into the receptive fields at
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the control site, both in control experiments without injection
(black line, N = 8), as well as during continuous AL injec-
tion (red line, N = 1). AL injection at the control site caused
some changes in behavior in comparison to the control data:
the injection experiment’s value for the threshold α was larger
than in all of the control experiments; at the same time, the
value for the slope β was smaller than in all of the control
experiments. AL injection did not cause changes in the lapse
rate (7 out of 8 control experiments had larger values for λ
than the injection experiment). These differences in behavior
are qualitatively different from the previously described changes
in behavior caused by injecting AL at the virus injection site.
In those experiments, we observed no changes in slope, and
significant changes in lapse rate, the opposite of the results
obtained when injecting AL at the control site. The only change
observed for both injection sites is the change in threshold.
However, injection of AL at the virus injection site caused the
threshold to change on average by σtexture = 0.6, while injec-
tion of AL at the control site only changed the threshold by
0.23. AL injection at a V1 site without AlstR expression there-
fore only had limited impact on the monkey’s performance.
In conclusion, our results in monkey W are consistent with
behavioral deficits caused by AL-mediated inactivation of the
AlstR-expressing neurons.
At the end of the experiment, we confirmed AlstR expression
by post-mortem histology. AlstR-expressing neurons were identi-
fied by staining for GFP. The virus injection site was clearly visible
as a region containing dense label (see Figure 3A for an example).
We quantified the efficiency of virus injection by computing the
density of infected neurons at the injection site. For this purpose,
we counted the number of neurons labeled with GFP in consecu-
tive sections spaced 400μm apart. Cell counts were Abercrombie
corrected to account for the distortion of cell counts in sectioned
tissue (Guillery, 2002). Glial cells could be distinguished from
neurons based on their different morphology and were excluded
from the cell count. For each section, we also determined the
volume of the tissue containing labeled neurons (see Materials
and Methods), to compute the density of GFP labeled neurons
for each section. The results of this analysis are listed in Table 1.
We also computed a rough estimate of the fraction of neurons
infected in each section, by comparing the density of labeled neu-
rons per section to the density of neurons in macaque cortex as
determined by Beaulieu et al. (Beaulieu et al., 1992). Differences
between layers were not taken into account in this analysis. It
should be noted that counting cells expressing GFP will result in
an underestimate of AlstR-expressing neurons for the following
reason: AlstR expression and GFP expression were coupled using
an IRES2 element. As a consequence, while all GFP-positive neu-
rons will also express the AlstR, there will be cells expressing the
AlstR that are not GFP-positive (Mizuguchi et al., 2000). The den-
sity of infected cells reported here is, therefore, only a lower bound
on the true infection efficiency.
As Table 1 shows, the number of infected neurons gradually
increased toward the center of the injection site. The maxi-
mum cell density, when computed across the entire section,
was about 3500 neurons/mm3, which corresponds to roughly
3% of all neurons. In addition to changes in infection density
across sections, the density of labeled neurons also changed
within each section. We, therefore, determined a spatial pro-
file of labeling density for each section by counting the number
of labeled neurons falling within windows of 100μm radius.
These windows were placed every 10μm. Figure 3D shows the
density profile of the section containing the largest number of
labeled cells. From these spatial density profiles, we could then
determine the maximum density of labeled neurons within the
100μm windows, both for each section, as well as across all sec-
tions. Across all sections, this resulted in a maximum density
of 12394.7 neurons/mm3, which corresponds to about 10.8% of
neurons being GFP-positive.
We repeated the experiments in monkey V, and injected virus
into V1, followed by AL injections at the same location. All exper-
imental procedures were nearly identical for the two animals.
Figure 4 shows monkey V’s performance in the detection task for
control experiments (black line, contralateral location: N = 41
for, AlstR location: N = 43) and during AL injection (red lines,
N = 3 for both locations). In this monkey, AL injection failed to
produce the same results as inmonkeyW, as performance was not
noticeably changed by AL injection at the AlstR location. A com-
parison of the parameters of the psychometric functions showed
no significant differences between control and injection data at
either target location (p > 0.01 for all parameters and target loca-
tions). Performance in the target-absent trials was also unaffected
by AL injection (U = 74, p = 1).
At the end of the experiments, we again tested for AlstR expres-
sion by staining for GFP. Unlike the findings in monkey W, we
observed only relatively sparse label in monkey V (see Figure 3B
for an example). Indeed, a quantification of the number of GFP
labeled neurons for this injection site resulted in much lower den-
sities of infected neurons (see Table 2). As Table 2 shows, the
density of labeled neurons computed across each entire section
did not exceed 1050 neurons/mm3, or roughly 1% of neurons
being GFP-positive. We also computed a spatial profile of label-
ing density for each section (see Figure 3E for the profile of the
section containing the densest label). For this injection site, the
local labeling density reached 6713.8 neurons/mm3 at the maxi-
mum (5.8% of neurons). In conclusion, both values indicate that
a much lower proportion of neurons were infected in monkey V
than in monkey W.
One possible reason for the differences between monkeys is
a difference in the injected virus. We used the same viral con-
struct in both monkeys, but two different batches that were
produced separately. To test whether the second batch of virus
was indeed infectious, we injected it again in monkey V. If
the low-levels of AlstR expression in this monkey were indeed
caused by the batch of virus used, we would expect to again see
low-levels of AlstR expression after the second injection. These
injections were performed about two months prior to perfu-
sion. Injections were placed at least 2mm away from the initial
virus injection site in V1. We placed four injections of 0.5μL
along a single long track through V1 and adjacent brain tissue,
with 1mm between injection sites. The post-mortem histology
revealed dense label within V1 following this second injection
(see Figure 3C). Table 3 lists the density of labeled neurons that
resulted from this virus injection. These numbers are comparable
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FIGURE 3 | Results of the post-mortem histology. (A–C) V1 sections
stained for GFP. Cells stained black are GFP-positive, which is co-localized
with AlstR expression. Scale bar: 100μm. (A) Tissue from monkey W.
(B) Section of V1 at the first virus injection site in monkey V. (C) V1 section at
the second injection site in monkey V. (D–F) Spatial profile of labeling density
for an example section for each injection site. The gray scale level in this
figure indicates the density of neurons computed within windows of 100μm
radius (see Materials and Methods). The white line markes the boundary of
the area in each section that contained labeled cells. Yellow lines indicate the
transition from gray matter to white matter (marked “WM”), and from brain
to pia (marked “P”). Scale bar: 100μm. (D) Monkey W. (E) First injection site
in monkey V. (F) Second injection site in monkey V.
to the densities observed in monkey W, with a maximal den-
sity of about 3400 neurons/mm3, or 3% of neurons. A spatial
density profile for one section is shown in Figure 3F. Across
all sections, the spatial analysis revealed that locally, the den-
sity of infected neurons reached 9296.0 neurons/mm3, or 8.1%
of neurons. Again, this is comparable to the density observed in
monkey W. The fact that we found AlstR expression after these
later injections, using the same batch of virus as used previously,
demonstrates that the failure of AlstR expression after the initial
injections in monkey V was not due to the particular batch of
virus used.
DISCUSSION
The importance of using viral vectors to introduce novel chan-
nels or receptors into neurons in the non-human primate brain
lies in the possibility of repeatable and cell-type specific manipu-
lations during the complex tasks that can be performed by these
animals. Previous studies have demonstrated that viruses can be
used to introduce novel channels or receptors into neurons in the
primate brain, which allow control over neural activity (Tan et al.,
2006; Han et al., 2009, 2011; Diester et al., 2011; Jazayeri et al.,
2011; O’Shea et al., 2011). Manipulations of neural activity can
in some cases be strong enough to influence behavior (Jazayeri
Frontiers in Systems Neuroscience www.frontiersin.org June 2012 | Volume 6 | Article 48 | 8
Nielsen et al. Behavioral consequences of AlstR-mediated inactivation
FIGURE 4 | Performance of monkey V in the detection task for control
and injection experiments, for targets shown at the contralateral and
AlstR location. Black circles and line: Average behavior and psychometric
function in control experiments (error bars: SEM). Red triangles and lines:
Performance (raw data and fit) in individual AL injection experiments.
Table 1 | For each section from monkey W containing labeled
neurons, the table lists the number of infected neurons, tissue
volume containing labeled neurons, density, and fraction of infected
neurons.
Section Number of Volume (mm3) Density % Neurons
infected (neurons/mm3) infected
neurons
1 164 0.08 1598.0 1.4
2 468 0.12 3321.8 2.9
3 373 0.09 3456.3 3.0
4 142 0.05 2120.5 2.0
Raw cell counts (before Abercrombie correction) are listed.
Table 2 | Summary of GFP expression for the first injection site in
monkey V.
Section Number of Volume (mm3) Density % Neurons
infected (neurons/mm3) infected
neurons
1 36 0.05 578.3 0.5
2 137 0.12 948.3 0.8
3 21 0.02 1057.1 0.9
et al., 2011; O’Shea et al., 2011). Here, we present additional evi-
dence that manipulating neural activity using a novel receptor can
be strong enough to influence a monkey’s performance in a task.
We used AAV1 to introduce the AlstR into neurons in area V1
in two monkeys trained to perform a detection task. In mon-
key W, AL injection at the same V1 site as the virus injection
caused a deficit in the detection task. This deficit was spatially
specific to targets placed at the retinotopic location of the virus
Table 3 | Summary of GFP expression for the second injection site in
monkey V.
Section Number of Volume (mm3) Density % Neurons
infected (neurons/mm3) infected
neurons
1 15 0.02 552.5 0.5
2 124 0.05 1953.2 1.7
3 259 0.06 3322.2 2.9
4 217 0.05 3405.4 3.0
5 122 0.05 2216.6 1.9
injection. Deficits were strong enough to affect even the most
easily detectable targets, as evidenced by a significant increase
in the lapse rate during AL injection. Saline injection, and AL
injection at a V1 site without AlstR expression, failed to produce
similar results. The deficits we observed are therefore most likely
due to AL-mediated inactivation of the AlstR-expressing neurons.
These effects are consistent with the behavioral deficits seen after
temporary inactivation of V1 using muscimol, a GABA agonist
(Newsome et al., 1985), or after V1 lesions (Cowey, 1962; Mohler
and Wurtz, 1977; Newsome et al., 1985; Moore et al., 1995). In
all of these experiments, monkeys failed to detect targets placed
in the part of the visual field represented by the inactivated part
of V1.
In monkey V, AL injection failed to produce similar behav-
ioral results, most likely due to a lack of sufficient expression of
the AlstR. An observation consistent with this explanation was
reported in the study by Tan et al. (Tan et al., 2006), in which AL
application failed to inactivate neurons in visual cortex in three
ferrets with very low AlstR expression levels. It is unclear why the
virus injections in monkey V failed to produce the same level of
AlstR expression as in monkey W. One possibility is a problem
with the particular batch of virus used for the injections in mon-
key V. However, a later injection using the same batch of virus led
to much stronger AlstR expression in monkey V.
Another possibility is a failure to deliver sufficient amounts of
virus during the injections, either because of incorrect placement
of the injection device, insufficient injection volume, or insuffi-
cient diffusion of virus into the brain. We placed injections using
a device consisting of a cannula with a metal electrode threaded
down its center, which allowed recordings of neural activity dur-
ing the injections. We used these recordings to confirm injection
depth, ensuring that the tip of the injection device was indeed
placed within V1. It therefore seems unlikely that the placement
of the injection device could have led to a failure to deliver virus
to V1.
Failure to express the AlstR could also be caused by injecting
a virus volume that is too small. Injection volumes were chosen
based on preliminary experiments in rats. In these experiments,
an injection of 1.5μL of virus, spread over three depths from
the surface of the brain, usually lead to AlstR expression up to
1mm away from the injection site (K. J. Nielsen, unpublished
observation). In the monkeys, we injected 1.5μL, again spread
over three depths, at four locations. The injections in monkey W
confirm that in principle this amount of virus can drive strong
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AlstR expression. However, the possibility remains that there was
a discrepancy between the amount of virus that we intended to
inject into V1, and the amount of virus actually injected. This
could be due to a measurement error, leading to an incorrect esti-
mate of the amount of virus leaving the injection device, or to
insufficient diffusion of virus into the brain. A volume measure-
ment error seems unlikely for the following reason: we injected
virus by connecting the injection device to a Hamilton syringe via
plastic tubing. When loading the virus into the injection device,
we first filled the syringe and a portion of the tubing with distilled
water before loading the virus. Virus and distilled water were kept
separate by an air bubble in the tubing between the two fluids.
The amount of virus injected was then measured by monitoring
the spatial displacement of the leading edge of the air bubble.
Because of the very limited compressibility of fluids, it seems
highly unlikely that we would have observed displacements of
the air bubble without delivering the corresponding fluid volume
to the brain. Furthermore, the diameter of the injection cannula
was large enough that we encountered no cases of clogging of the
injection device.
A much more likely reason is insufficient diffusion of the virus
into adjacent brain tissue. Nicholson (Nicholson, 1985) describes
two possible scenarios after injection of fluid into the brain: in
one the fluid generates a cavity in the tissue around the injection
site; in the other, fluid actually diffuses into the brain. In addi-
tion, there will likely also be reflux of fluid along the injection
device. Parameters like injection speed and pressure, the shape
of the injection device, and the angle of insertion into the brain
will influence the success of an injection, i.e., how much of the
injected virus actually diffuses into the brain. Since we performed
injections through guide tubes inserted into the dura, the surface
of the brain was not visible, and we could not assess a number
of these parameters. To increase the success of future studies rely-
ing on virus injections into the brain, it would be ideal to find
ways to monitor the actual diffusion into the brain while placing
injections. One such strategy involves co-injecting the virus with
an MRI tracer, and monitoring the diffusion of this tracer using
real-time MR imaging (Salegio et al., 2011).
Lastly, an immune response against the injected virus also
needs to be considered as a reason for the lack of AlstR expres-
sion in monkey V. High titers of neutralizing antibodies against
AAV2 have been found to interfere with AAV2 injections into the
brain: AAV2 injections in animals pre-immunized against AAV2
may lead to lower expression levels than injections in naïve ani-
mals (Peden et al., 2004; Sanftner et al., 2004). In this study we
injected AAV1, for which immune responses to injections into
the brain have not been studied. However, the AAV1 serotype has
been isolated from primates (Rapoza, 1967; Parks et al., 1970).
AAV infections have no known disease association and only cause
very mild immune responses, so we cannot completely rule out
that monkey V had higher than normal antibody titers against
AAV1 during the time of the initial virus injections. However,
this possibility seems unlikely given that at the time of injections
the monkey had been part of a stable primate colony for several
years. Nonetheless, because immune responses can influence the
outcome of AAV injections into the brain, future studies using
AAV in the non-human primate should consider pre-screening
the animals for antibody titers against the chosen AAV serotype.
Along the same lines, an immune response should be considered
when planning repeated injections: immune responses triggered
by a first AAV injection may reduce expression levels of a follow-
ing injection of the same virus when done to quickly after the first
injection (Mastakov et al., 2002; Peden et al., 2004, 2009).
In conclusion, we suspect that differences in the virus diffu-
sion into V1 are the main reason for the differences in AlstR
expression between monkeys W and V. Since injections were per-
formed using identical methods in both monkeys, the cause for
these differences remains unclear.
The variability in expression levels across animals observed in
our experiments highlight a general challenge for future studies
using viral vector-based approaches in the monkey. To minimize
the number of animals required per study, it will be necessary
to confirm the success of each virus injection in vivo to ensure
sufficient expression levels of the chosen channel or receptor. In
most circumstances, viral vectors are designed to not only drive
expression of a novel channel or receptor, but also of a fluorescent
protein, such as the GFP used here. In some cases, the channels or
receptors themselves have been engineered to be fluorescent. One
example of the latter case is ChR2, which has been made fluores-
cent by fusion with YFP (Boyden et al., 2005). Fluorescence levels
can thus be used to verify the expression levels achieved after a
virus injection. The complication in the non-human primate is
the opacity of the dura, which does not allow direct visualiza-
tion of the brain. One technique that circumvents this problem
and allows quantification of fluorescence levels in vivo even in
the primate brain was developed by Diester et al. (Diester et al.,
2011). It is based on an optical fiber which is lowered into the
brain through a guide tube. Diester et al. have demonstrated
that this device can be used to measure fluorescence generated
from expression of ChR2-YFP in the monkey brain. A possible
disadvantage of this approach is tissue damage caused by the rel-
atively large optical fiber; however, the device has the advantage
of being suitable even for deeper brain areas. Another possibility
to detect fluorescence in a surface area is the use of an artificial
dura implant (Shtoyerman et al., 2000; Roe, 2007). In this case,
the dura over the brain region of interest is replaced with a trans-
parent sheet of silicone, allowing access to the brain for optical
methods, and therefore possibly the quantification of fluorescence
levels generated by virus injections (Heider et al., 2010).
Despite the technical obstacles encountered when using viral
vector-based techniques in the non-human primate, the approach
still holds enormous promise because of the selectivity with which
certain types of neurons can be targeted. A number of strate-
gies have been developed to restrict the expression of novel genes
to a selected population of neurons. The choice of promoter or
viral vector used, for example, can bias expression to certain neu-
rons (Dittgen et al., 2004; Nathanson et al., 2009). This approach
is widely used in rodent studies; an example of limiting expres-
sion of ChR2 to excitatory neurons in the monkey brain can be
found in Han et al. (Han et al., 2009). Another strategy suitable
to limit expression of novel genes to certain neurons is the use of
so called bridge proteins (Choi et al., 2010). This strategy relies
on limiting which neurons a virus can infect, instead of limiting
the expression of the novel genes. For this purpose, viruses
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are generated such that they can only infect neurons express-
ing a particular membrane protein. Yet another strategy relies
on using retrogradely transmitted viruses to target projection
neurons. These viruses—such as rabies-pseudotyped lentiviruses
(Mazarakis et al., 2001)—are taken up at synapses, and therefore
lead to gene expression in the neurons projecting to an area.
By choosing the right approach, it should be possible in the
future to restrict expression of a novel channel or receptor to a
certain type of neuron, and to test the involvement of that neu-
ron type in a particular brain function or behavior. This will not
only provide valuable insights into brain function in general, it
will also yield results important to understand possible causes
of neurological disorders. Changes in certain inhibitory neu-
rons have for example been proposed to underlie disorders such
as schizophrenia (Lewis et al., 2005) and epilepsy (de Lanerolle
et al., 1989). Similarly, autism is thought to be due to discon-
nections between frontal cortex and other higher-order areas
of the cerebral cortex (Geschwind and Levitt, 2007). Monkeys
are able to perform the complex behavioral tasks required to
study these disorders, and cell-type or circuit-specific manipula-
tions in the monkey will therefore provide a much more detailed
understanding of their etiology.
In summary, our results demonstrate that viral vector-based
approaches allow manipulations of brain activity strong enough
to influence a monkey’s behavior. This opens the door to probe
the involvement of specific classes of neurons in the complex
behavioral tasks that monkeys are uniquely qualified to perform.
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